Evidence map›Paper›PMID 41830325›Full record

ArticleNucleic acids research2026

Multiplexed TrAEL-seq captures DNA replication dynamics in mammalian cells.

Neesha Kara, Laura Biggins, Alex Whale, Kieron May, Vera Grinkevich, Paola Garran-Garcia, Jhanavi Srinivasan, Peter J Rugg-Gunn, Claudia Ribeiro de Almeida, Samantha J Walker and 6 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Neesha KaraEpigenetics programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0003-2646-1473
Laura BigginsBabraham Bioinformatics, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0002-0975-1121
Alex WhaleEpigenetics programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0003-4568-711X
Kieron MayEpigenetics programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0002-7307-6976
Vera GrinkevichArtios Pharma, Babraham Research Campus, CB22 3AT Babraham, United Kingdom.ORCID 0000-0001-7778-8826
Paola Garran-GarciaEpigenetics programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0009-0009-1212-1620
Jhanavi SrinivasanEpigenetics programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.
Peter J Rugg-GunnEpigenetics programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0002-9601-5949
Claudia Ribeiro de AlmeidaImmunology Programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0002-1462-5453
Samantha J WalkerSomatic Genomics Programme, Wellcome Sanger Institute, Cambridge, United Kingdom.ORCID 0009-0006-9002-5966
Gabriele PiccoSomatic Genomics Programme, Wellcome Sanger Institute, Cambridge, United Kingdom.ORCID 0000-0001-8568-2781
Mathew J GarnettSomatic Genomics Programme, Wellcome Sanger Institute, Cambridge, United Kingdom.ORCID 0000-0002-2618-4237
Simon AndrewsBabraham Bioinformatics, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0002-5006-3507
Aled ParryEpigenetics programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0001-5192-3727
Helen M R RobinsonArtios Pharma, Babraham Research Campus, CB22 3AT Babraham, United Kingdom.
Jonathan HouseleyEpigenetics programme, Babraham Institute, CB22 3AT Babraham, United Kingdom.ORCID 0000-0001-8509-1500

Funding

BBSRC BB/Y512515/1BBSRC BI Epigenetics ISP BBS/E/B/000C0523]BBSRC BI Immunology ISP BB/Y006917/1]Campus Capability Grant (CCG) BB/CCG2310/1InsMed MR/T011769/1MRCWellcome Trust 206194Wellcome Trust 215912/Z/19/ZWellcome Trust 220196/Z/20/ZWellcome Trust 220540/Z/20/AWellcome Trust 225839/Z/22/Z
6 · The paper itself

Abstract

TrAEL-seq is a robust method for profiling DNA replication genome-wide that works in unsynchronized cells and does not require drugs or nucleotide analogues. Here, we provide an updated method for TrAEL-seq that improves sample quality and includes multiplexing of up to six samples which dramatically improves throughput, and we validate TrAEL-seq in multiple mammalian cell lines. The updated protocol is straightforward and robust yet provides excellent resolution comparable to OK-seq in mammalian cell samples. High resolution replication profiles can be obtained across large panels of samples and in dynamic systems, for example during the progressive onset of oncogene induced senescence. In addition to mapping zones where replication initiates and terminates, TrAEL-seq is sensitive to replication fork speed, revealing effects of both transcription and proximity to replication Initiation Zones on fork progression. Although forks move more slowly through transcribed regions, this does not have a significant impact on the broader dynamics of replication fork progression, and instead replication forks accelerate across the first ∼1 Mb of travel irrespective of local transcriptional activity. We propose that this is a consequence of fewer replication forks being active later in S-phase when these distal regions replicate and there being less competition for replication factors.

Indexed as

DNA ReplicationHigh-Throughput Nucleotide SequencingSequence Analysis, DNAAnimalsCell LineHumansReplication OriginTranscription, Genetic

Identifiers

PMID41830325
PMCPMC12988324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.